You are here

  • Home
  • Archive
  • Volume 77, Issue Suppl 2
  • THU0043 Autoantibody profiling in prostvac and ipilimumab treated prostate cancer patients reveals potential biomarkers of immune-related adverse events

Article metrics

Article menu

Download PDFPDF

THURSDAY, 14 JUNE 2018:
Adaptive immunity (T cells and B cells) in rheumatic diseases
THU0043 Autoantibody profiling in prostvac and ipilimumab treated prostate cancer patients reveals potential biomarkers of immune-related adverse events
Free

 

Online download statistics by month:

Online download statistics by month: June 2018 to March 2024

AbstractFullPdf
Jun 201832010
Jul 20182202
Aug 20181201
Sep 20181602
Oct 20181602
Nov 20181801
Dec 20182604
Jan 20193404
Feb 20191001
Mar 20194006
Apr 20192803
May 20191603
Jun 20191402
Jul 20191002
Aug 20192202
Sep 20191001
Oct 20191407
Nov 2019802
Dec 2019600
Jan 2020601
Feb 2020201
Mar 2020601
Apr 2020401
May 2020302
Jun 20201001
Jul 20202002
Aug 20201803
Sep 20203106
Oct 2020400
Nov 20201305
Dec 20201403
Jan 2021606
Feb 20211204
Mar 2021802
Apr 20211403
May 2021604
Jun 2021002
Jul 2021002
Aug 2021002
Sep 2021007
Oct 202110015
Nov 20210010
Dec 20211206
Jan 2022703
Feb 20221601
Mar 20221601
Apr 20222604
May 202214011
Jun 202230010
Jul 20221601
Aug 20227006
Sep 20223909
Oct 20222203
Nov 20223005
Dec 20222803
Jan 20232405
Feb 20233303
Mar 20234703
Apr 20233205
May 20231504
Jun 20231002
Jul 20231408
Aug 20231602
Sep 20231404
Oct 20231702
Nov 20232601
Dec 20232601
Jan 20242002
Feb 20241102
Mar 20241402
Total11860247